bexarotene has been researched along with Cranial Nerve II Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JWL; Chard, DT; Coles, AJ; Cunniffe, NG; Franklin, RJM; McMurran, CE; Michell, AW; Mukherjee, T | 1 |
1 other study(ies) available for bexarotene and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Remyelination in humans due to a retinoid-X receptor agonist is age-dependent.
Topics: Age Factors; Aged; Animals; Bexarotene; Evoked Potentials, Visual; Humans; Multiple Sclerosis; Optic Nerve Diseases; Peripheral Nervous System Agents; Remyelination; Retinoid X Receptors; Retinoids | 2022 |